Report Summary
Eternity Insights has published a new study on Global Glucose Monitoring Device Market focusing on key segments as by Type (Diabetes monitoring devices, Insulin delivery devices, Other), by Application (Hospitals, Personal use, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Glucose Monitoring Device Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Glucose Monitoring Device Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Glucose Monitoring Device Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Glucose Monitoring Device Market Segmentation:
Glucose Monitoring Device Market, By Type
- Diabetes monitoring devices
- Insulin delivery devices
- Other
Glucose Monitoring Device Market, By Application
- Hospitals
- Personal use
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Glucose Monitoring Device market in terms of demand generation. The Glucose Monitoring Device market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Glucose Monitoring Device market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Glucose Monitoring Device Market Taxonomy:
To learn more about this report
Global Glucose Monitoring Device Market Competitive Landscape
The global Glucose Monitoring Device market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Roche
- DexCom
- Johnson & Johnson
- AstraZeneca
- Insulet
- Sanofi
- Merck
- GSK
- Nova Biomedical
- Becton Dickinson
- Eli Lilly
- Lupin
- Braun
- Takeda Pharmaceutical
- Bayer HealthCare
- Abbott Diabetes Care
- Boehringer Ingelheim
- Novo Nordisk
- GlySens
- Senseonics
- Novartis
- Omron Healthcare
- Philips Healthcare
- GE Healthcare
- Medtronic
- ResMed
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Diabetes monitoring devices, Insulin delivery devices, Other |
| By Application Outlook |
Hospitals, Personal use, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, Eli Lilly, Lupin, Braun, Takeda Pharmaceutical, Bayer HealthCare, Abbott Diabetes Care, Boehringer Ingelheim, Novo Nordisk,GlySens, Senseonics, Novartis, Omron Healthcare, Philips Healthcare, GE Healthcare, Medtronic,ResMed |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Glucose Monitoring Device Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Glucose Monitoring Device Market Size Growth Rate by Product
1.4.2 Diabetes monitoring devices
1.4.3 Insulin delivery devices
1.5 Market by End User
1.5.1 Global Glucose Monitoring Device Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Personal use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glucose Monitoring Device Market Size
2.1.1 Global Glucose Monitoring Device Revenue 2014-2025
2.1.2 Global Glucose Monitoring Device Sales 2014-2025
2.2 Glucose Monitoring Device Growth Rate by Regions
2.2.1 Global Glucose Monitoring Device Sales by Regions
2.2.2 Global Glucose Monitoring Device Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Glucose Monitoring Device Sales by Manufacturers
3.1.1 Glucose Monitoring Device Sales by Manufacturers
3.1.2 Glucose Monitoring Device Sales Market Share by Manufacturers
3.1.3 Global Glucose Monitoring Device Market Concentration Ratio (CR5 and HHI)
3.2 Glucose Monitoring Device Revenue by Manufacturers
3.2.1 Glucose Monitoring Device Revenue by Manufacturers (2017-2020)
3.2.2 Glucose Monitoring Device Revenue Share by Manufacturers (2017-2020)
3.3 Glucose Monitoring Device Price by Manufacturers
3.4 Glucose Monitoring Device Manufacturing Base Distribution, Product Types
3.4.1 Glucose Monitoring Device Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucose Monitoring Device Product Type
3.4.3 Date of International Manufacturers Enter into Glucose Monitoring Device Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Glucose Monitoring Device Sales by Product
4.2 Global Glucose Monitoring Device Revenue by Product
4.3 Glucose Monitoring Device Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Glucose Monitoring Device Breakdown Data by End User
6 North America
6.1 North America Glucose Monitoring Device by Countries
6.1.1 North America Glucose Monitoring Device Sales by Countries
6.1.2 North America Glucose Monitoring Device Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Glucose Monitoring Device by Product
6.3 North America Glucose Monitoring Device by End User
7 Europe
7.1 Europe Glucose Monitoring Device by Countries
7.1.1 Europe Glucose Monitoring Device Sales by Countries
7.1.2 Europe Glucose Monitoring Device Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glucose Monitoring Device by Product
7.3 Europe Glucose Monitoring Device by End User
8 Asia Pacific
8.1 Asia Pacific Glucose Monitoring Device by Countries
8.1.1 Asia Pacific Glucose Monitoring Device Sales by Countries
8.1.2 Asia Pacific Glucose Monitoring Device Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Glucose Monitoring Device by Product
8.3 Asia Pacific Glucose Monitoring Device by End User
9 Central & South America
9.1 Central & South America Glucose Monitoring Device by Countries
9.1.1 Central & South America Glucose Monitoring Device Sales by Countries
9.1.2 Central & South America Glucose Monitoring Device Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Glucose Monitoring Device by Product
9.3 Central & South America Glucose Monitoring Device by End User
10 Middle East and Africa
10.1 Middle East and Africa Glucose Monitoring Device by Countries
10.1.1 Middle East and Africa Glucose Monitoring Device Sales by Countries
10.1.2 Middle East and Africa Glucose Monitoring Device Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Glucose Monitoring Device by Product
10.3 Middle East and Africa Glucose Monitoring Device by End User
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Roche Glucose Monitoring Device Products Offered
11.1.5 Roche Recent Development
11.2 DexCom
11.2.1 DexCom Company Details
11.2.2 Company Business Overview
11.2.3 DexCom Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.2.4 DexCom Glucose Monitoring Device Products Offered
11.2.5 DexCom Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Johnson & Johnson Glucose Monitoring Device Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 Company Business Overview
11.4.3 AstraZeneca Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.4.4 AstraZeneca Glucose Monitoring Device Products Offered
11.4.5 AstraZeneca Recent Development
11.5 Insulet
11.5.1 Insulet Company Details
11.5.2 Company Business Overview
11.5.3 Insulet Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Insulet Glucose Monitoring Device Products Offered
11.5.5 Insulet Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Sanofi Glucose Monitoring Device Products Offered
11.6.5 Sanofi Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Business Overview
11.7.3 Merck Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Merck Glucose Monitoring Device Products Offered
11.7.5 Merck Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 Company Business Overview
11.8.3 GSK Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.8.4 GSK Glucose Monitoring Device Products Offered
11.8.5 GSK Recent Development
11.9 Nova Biomedical
11.9.1 Nova Biomedical Company Details
11.9.2 Company Business Overview
11.9.3 Nova Biomedical Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Nova Biomedical Glucose Monitoring Device Products Offered
11.9.5 Nova Biomedical Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Details
11.10.2 Company Business Overview
11.10.3 Becton Dickinson Glucose Monitoring Device Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Becton Dickinson Glucose Monitoring Device Products Offered
11.10.5 Becton Dickinson Recent Development
11.11 Eli Lilly
11.12 Lupin
11.13 Braun
11.14 Takeda Pharmaceutical
11.15 Bayer HealthCare
11.16 Abbott Diabetes Care
11.17 Boehringer Ingelheim
11.18 Novo Nordisk
11.19 GlySens
11.20 Senseonics
11.21 Novartis
11.22 Omron Healthcare
11.23 Philips Healthcare
11.24 GE Healthcare
11.25 Medtronic
11.26 ResMed
12 Future Forecast
12.1 Glucose Monitoring Device Market Forecast by Regions
12.1.1 Global Glucose Monitoring Device Sales Forecast by Regions 2019-2025
12.1.2 Global Glucose Monitoring Device Revenue Forecast by Regions 2019-2025
12.2 Glucose Monitoring Device Market Forecast by Product
12.2.1 Global Glucose Monitoring Device Sales Forecast by Product 2019-2025
12.2.2 Global Glucose Monitoring Device Revenue Forecast by Product 2019-2025
12.3 Glucose Monitoring Device Market Forecast by End User
12.4 North America Glucose Monitoring Device Forecast
12.5 Europe Glucose Monitoring Device Forecast
12.6 Asia Pacific Glucose Monitoring Device Forecast
12.7 Central & South America Glucose Monitoring Device Forecast
12.8 Middle East and Africa Glucose Monitoring Device Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucose Monitoring Device Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
